Pesquisar | Friends - Best Social Network - החברים

Alex Thomas adicionou um novo artigo Outro
2025-10-09 09:35:54

Duchenne Muscular Dystrophy Drugs Market Size 2034
Duchenne Muscular Dystrophy (DMD) drugs are specialized therapies aimed at managing and treating DMD, a rare and severe genetic disorder caused by mutations in the dystrophin gene. This condition leads to progressive muscle degeneration and weakness, primarily affecting boys from early childhood. While there is no definitive cure, current drugs focus on slowing disease progression, improving...

0 Comentários 0 Compartilhamentos 282 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Sindhuri Kotamraju adicionou um novo artigo Health
2025-09-10 13:40:31

North America Duchenne Muscular Dystrophy (DMD) Treatment Market to Surpass USD 8.84 Billion by 2033, Fueled by 20.2% CAGR
The North America Duchenne Muscular Dystrophy (DMD) Treatment Market was valued at US$ 2.06 billion in 2024 and is projected to reach US$ 8.84 billion by 2033, growing at a remarkable CAGR of 20.2% from 2025 to 2033. DMD is a severe, progressive genetic disorder characterized by muscle weakness and degeneration, predominantly affecting young boys. Despite being rare, the high disease burden...

0 Comentários 0 Compartilhamentos 319 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Devidi Jahnavi adicionou um novo artigo Outro
2025-09-16 13:29:30

North America Duchenne Muscular Dystrophy Treatment Market Future Scope | Opportunities and Growth Trends 2025–2033
Overview of the North America MASH Treatment Market The North America Metabolic Dysfunction-Associated Steatohepatitis Treatment Market is experiencing unprecedented growth, primarily fueled by rising rates of obesity, diabetes, and metabolic syndrome, which are major risk factors for MASH, formerly known as NASH (Nonalcoholic Steatohepatitis). As of 2024, the market reached a value...

0 Comentários 0 Compartilhamentos 355 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Devidi Jahnavi adicionou um novo artigo Outro
2025-09-17 11:08:18

North America Duchenne Muscular Dystrophy Treatment Market Future Scope | Opportunities and Growth Trends 2025–2033
Overview of the North America Duchenne Muscular Dystrophy Treatment Market According to DataM Intelligence, the North America Duchenne Muscular Dystrophy Treatment Market size was valued at approximately US$2.06 billion in 2024 and is projected to reach about US$8.84 billion by 2033, expanding at a strong CAGR of around 20.2% during 2025-2033. The market is...

0 Comentários 0 Compartilhamentos 285 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Devidi Jahnavi adicionou um novo artigo Health
2025-06-17 07:02:31

The Role of CRISPR and AAV in Duchenne Gene Repair
Duchenne Muscular Dystrophy (DMD) is a rare, progressive neuromuscular disorder that leads to severe muscle degeneration and early mortality. Affecting roughly 1 in 3,500 to 5,000 male births globally, DMD stems from mutations in the DMD gene, which encodes dystrophin, a protein critical for muscle fiber integrity. Without dystrophin, muscle cells become fragile and eventually die, leading to...

0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Uttej Netha adicionou um novo artigo Health
2025-07-01 04:53:54

High Therapy Costs Remain Barrier Despite Market Growth to USD 8.84B
The North America Duchenne Muscular Dystrophy (DMD) Treatment Market is set for significant growth, expanding from USD 2.06 billion in 2024 to USD 8.84 billion by 2033, at an impressive compound annual growth rate (CAGR) of 20.2% during the period 2025–2033. Download Sample Report:...

0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!